Literature DB >> 17033693

Inflammation after intracerebral hemorrhage.

Jian Wang1, Sylvain Doré.   

Abstract

Intracerebral hemorrhage (ICH) is a devastating clinical event without effective therapies. Increasing evidence suggests that inflammatory mechanisms are involved in the progression of ICH-induced brain injury. Inflammation is mediated by cellular components, such as leukocytes and microglia, and molecular components, including prostaglandins, chemokines, cytokines, extracellular proteases, and reactive oxygen species. Better understanding of the role of the ICH-induced inflammatory response and its potential for modulation might have profound implications for patient treatment. In this review, a summary of the available literature on the inflammatory responses after ICH is presented along with discussion of some of the emerging opportunities for potential therapeutic strategies. In the near future, additional strategies that target inflammation could offer exciting new promise in the therapeutic approach to ICH.

Entities:  

Mesh:

Year:  2006        PMID: 17033693     DOI: 10.1038/sj.jcbfm.9600403

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  279 in total

Review 1.  Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.

Authors:  Wei Wang; Mingchang Li; Qianxue Chen; Jian Wang
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

2.  Proteasome Inhibitor Reduces Astrocytic iNOS Expression and Functional Deficit after Experimental Intracerebral Hemorrhage in Rats.

Authors:  Fahmi M Al-Senani; Xiurong Zhao; James C Grotta; Ali Shirzadi; Roger Strong; Jaroslaw Aronowski
Journal:  Transl Stroke Res       Date:  2011-10-19       Impact factor: 6.829

3.  Astrogliosis: a target for intervention in intracerebral hemorrhage?

Authors:  Sangeetha Sukumari-Ramesh; Cargill H Alleyne; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2012-04-14       Impact factor: 6.829

4.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

5.  Depletion of GR-1-Positive Cells Is Associated with Reduced Neutrophil Inflammation and Astrocyte Reactivity after Experimental Intracerebral Hemorrhage.

Authors:  Matthew C Loftspring; Holly L Johnson; Aaron J Johnson; Joseph F Clark
Journal:  Transl Stroke Res       Date:  2012-05-02       Impact factor: 6.829

6.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

7.  Clinical trials for neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside.

Authors:  Amit Ayer; Brian Y Hwang; Geoffrey Appelboom; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-08-14       Impact factor: 6.829

8.  Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings.

Authors:  Robert Brunkhorst; Waltraud Pfeilschifter; Christian Foerch
Journal:  Transl Stroke Res       Date:  2010-08-28       Impact factor: 6.829

9.  Increased expression of small heat shock protein αB-crystallin after intracerebral hemorrhage in adult rats.

Authors:  Kaifu Ke; Lei Li; Ying Rui; Heyi Zheng; Xiang Tan; Wei Xu; Jianhua Cao; Jian Xu; Gang Cui; Guangfei Xu; Maohong Cao
Journal:  J Mol Neurosci       Date:  2013-02-06       Impact factor: 3.444

10.  Poloxamer-188 can attenuate blood-brain barrier damage to exert neuroprotective effect in mice intracerebral hemorrhage model.

Authors:  Tao Wang; Xiping Chen; Zufeng Wang; Mingyang Zhang; Huanhuan Meng; Yuan Gao; Bin Luo; Luyang Tao; Yijiu Chen
Journal:  J Mol Neurosci       Date:  2014-04-29       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.